References
[1] Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: Lessons from rheumatoid arthritis. Eur Heart J 2017;38:1717-1727. https://doi.org/10.1093/eurheartj/ehw208.
[2] Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-3347. https://doi.org/10.1161/CIRCULATIONAHA.104.507996.
[3] Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S, Bisogno S, et al, Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med 2013;24:368-374. http://doi.org/10.1016/j.ejim.2013.02.009.
[4] Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum 2005;52:402-411. https://doi.org/10.1002/art.20853.
[5] Chauhan K, Ackerman MJ, Crowson CS, Matteson EL, Gabriel SE. Population-based study of QT interval prolongation in patients with rheumatoid arthritis. Clin Exp Rheumatol 2015;33:84.
[6] Kobayashi H, Kobayashi Y, Yokoe I, Kitamura N, Nishiwaki A, Takei M, Giles JT. Heart rate–corrected qt interval duration in rheumatoid arthritis and its reduction with treatment with the interleukin 6 inhibitor tocilizumab. J Rheumatol 2018;45:1620-1627. https://doi.org/10.3899/jrheum.180065.
[7] Lazzerini PE, Capecchi PL, Laghi-Pasini F. Long QT syndrome: An emerging role for inflammation and immunity. Front Cardiovasc Med 2015;2:26. https://doi.org/10.3389/fcvm.2015.00026.
[8] Panoulas VF, Toms TE, Douglas KMJ, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: An association driven by high inflammatory burden. Rheumatology (Oxford) 2014;53:131-137. https://doi.org/10.1093/rheumatology/ket338.
[9] Seferović PM, Ristić AD, Maksimović R, Simeunović DS, Ristić GG, Radovanović G, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) 2006;45(suppl. 4):iv39-iv42. https://doi.org/10.1093/rheumatology/kel315.
[10] Terao C, Hashimoto M, Yamamoto K, Murakami K, Ohmura K, Nakashima R, et al. Three groups in the 28 joints for rheumatoid arthritis synovitis - Analysis using more than 17,000 assessments in the KURAMA database. PLOS ONE 2013;8:e59341. https://doi.org/10.1371/journal.pone.0059341.
[11] Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. Part IV: The ST Segment, T and U waves, and the QT interval A scientific statement from the American Heart Association electrocardiography and Arrhythmias Co. J Am Coll Cardiol 2009;53:982-991. http://doi.org/10.1016/j.jacc.2008.12.014.
[12] Al-Khatib SM, LaPointe NMA, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003;289:2120-2127. https://doi.org/10.1001/jama.289.16.2120.
[13] Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ. Department of Health and Social Security Hypertension Care Computer Project (DHCCP). Left ventricular hypertrophy determined by Sokolow–Lyon criteria: A different predictor in women than in men? J Hum Hypertens 2006;20:451-459. https://doi.org/10.1038/sj.jhh.1002006.
[14] Aletaha D, Smolen J. The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): A review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23(suppl. 39):S100-S108.
[15] Sordillo PP, Sordillo DC, Helson L. Review: The prolonged QT interval: Role of pro-inflammatory cytokines, reactive oxygen species and the ceramide and sphingosine-1 phosphate pathways. In Vivo 2015;29:619-636.
[16] Cacciapaglia F, Fornaro M, Venerito V, Perniola S, Urso L, Iannone F. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis. Eur J Clin Investig 2020;50:1-8.
[17] da Mota LMH, Laurindo IMM, de Carvalho JF, dos Santos-Neto LL. Prognostic evaluation of early rheumatoid arthritis. Swiss Med Wkly 2010;140:w13100. https://doi.org/10.4414/smw.2010.13100.
[18] Cui K, Movahedi M, Bombardier C, Kuriya B. Cardiovascular risk factors are negatively associated with rheumatoid arthritis disease outcomes. Ther Adv Musculoskelet Dis 2021;13:X20981217. http://www.ncbi.nlm.nih.gov/pubmed/1759720.
[19] Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: State of the art and future perspectives. Ann Rheum Dis 2011;708-14. https://doi.org/10.1136/ard.2010.142133.
[20] Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: Mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 2015;36:482-49c. https://doi.org/10.1093/eurheartj/ehu403.
[21] Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 2004;22:63-70.
[22] Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in heart failure: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:1324-1340. https://doi.org/10.1016/j.jacc.2020.01.014.
[23] Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004;95:754-763. https://doi.org/10.1161/01.RES.0000145047.14691.db.
[24] Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis 2014;73:1797-1804. https://doi.org/10.1136/annrheumdis-2013-203617.
[25] Puntmann VO, Taylor PC, Barr A, Schnackenburg B, Jahnke C, Paetsch I. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: A magnetic resonance imaging study. Rheumatology 2009;49:528-535. https://doi.org/10.1093/rheumatology/kep426.
[26] Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992;86:1376-1382. https://doi.org/10.1161/01.cir.86.5.1376.